Abstract Background Internalizing disorders and cardiometabolic disease are common conditions that frequently co-occur in later life and may be attributed to shared genetic influences. While phenotypic effects of polygenic liability of adult disorders may emerge early in life, studies have not investigated this in the context of multimorbidity. This study set out to investigate early manifestations of polygenic liability to adult internalizing-cardiometabolic multimorbidity (ICM-MM) in a UK population birth cohort. Methods We used data from 5,821 individuals in the Avon Longitudinal Study of Parents and Children (ALSPAC). We modelled trajectories of 12 mental and cardiometabolic health outcomes using mixed effects models, and investigated effects of adult ICM-MM polygenic liability on these trajectories. We also investigated associations of adult ICM-MM polygenic liability with circulating inflammatory proteins (Olink Target 96 Inflammation panel) at ages 9 and 24. Results Adult ICM-MM polygenic liability is associated with cardiometabolic traits and inflammation, and with changes in depressive symptoms and cardiometabolic traits over time in childhood through to early adulthood. A notable early life biological footprint is inflammation. We found that higher ICM-MM polygenic liability is consistently associated with higher interleukin-6 (IL6), tumor necrosis family superfamily member 14 (TNFSF14) and hepatocyte growth factor (HGF) levels in both childhood and early adulthood. Conclusions Adult ICM-MM polygenic liability manifests early in life through changes in mental and cardiometabolic health and blood biomarkers, especially in increases of circulating inflammatory proteins related to obesity, immune cell chemotaxis and migration that may contribute to disease pathogenesis by seeding inflammation in relevant tissues.

BACKGROUND:UK South Asian populations are at high risk of physical and mental health multimorbidity, which means they live with multiple long-term conditions. The life course emergence of multimorbidity, its underlying aetiology, and consequences for future health and mortality have yet to be studied in this population. METHODS AND FINDINGS:We studied Internalising (depression, anxiety, somatoform disorders) and Cardiometabolic (hypertension, obesity, type 2 diabetes, chronic kidney disease, dyslipidaemia) MultiMorbidity (ICM-MM): the lifetime occurrence of ≥1 internalising mental health condition AND ≥1 cardiometabolic condition in a longitudinal cohort of Genes and Health study participants with linked genetic and health data from 1st April 1997-24th November 2024. We used multi-state models to investigate trajectories in ICM-MM and risk of major cardiovascular or renal events (CVR) or non-CVR death. We used flexible parametric models to estimate baseline hazards for health state transitions, adjusting for sociodemographic factors, a polygenic risk score (PRS) for ICM-MM (ICM-MMPRS), and describe 10-year simulated health state probabilities. Over 10.2 years median follow-up of 23,554 British Bangladeshi and Pakistani participants (median baseline age 31.1 years, 12,934 [54.9%] women), 3,159 (13.4%) developed ICM-MM; 1,522 (6.5%) CVR; and there were 103 (0.4%) non-CVR deaths. Women were less likely to remain healthy, with higher probability of developing internalising conditions and subsequent ICM-MM, but lower risk of CVR than men. Younger age was associated with higher risk of developing internalising conditions. Bangladeshi ethnicity, higher deprivation, and smoking were all associated with higher probability of ICM-MM. 10-year CVR risk was highest for people who developed ICM-MM via the trajectory cardiometabolic-to-internalising (versus internalising-to-cardiometabolic) in mid-life (age 40). Higher ICM-MMPRS was associated with higher probability of ICM-MM via cardiometabolic conditions rather than internalising conditions. Our findings are based on routinely collected electronic health records from East London, which incompletely capture individual-level and time-varying risk factors, remission or recovery, and may not reflect British Bangladeshi and British Pakistani communities across the UK. The PRS was derived largely from GWAS of European ancestry populations, which may limit its transferability to this cohort. CONCLUSIONS:The burden of multimorbidity is high in British Bangladeshi and British Pakistani populations. Young Bangladeshi women are at high risk of ICM-MM, while men are at higher risk of CVR. Detection and intervention strategies for physical and mental health multimorbidity should be targeted early in the lifecourse, for those at highest risk.

Background and Aims To elucidate the genetic architecture of blood pressure (BP) and heart rate (HR) during early life and assess their potential relevance to adult health outcomes.Methods The largest genome-wide association study (GWAS) meta-analyses to date of childhood systolic BP, diastolic BP, pulse pressure, and mean arterial pressure (n = 28 425) and HR (n = 22 565) were conducted in children of European ancestry aged 4-17 years. Follow-up analyses included comparisons with adult GWAS results, polygenic risk score (PRS) analyses in independent cohorts of diverse ancestries, and a phenome-wide association study in the UK Biobank.Results Eight genome-wide significant loci were identified for childhood BP (KIAA2013, CACNB2, PLCE1, PAX2, COL4A2, RP11-236L14.1, CFDP1, TPX2) and three loci for childhood HR (CCDC141, ACHE, MYH6); all novel in children but previously reported in adults. Childhood PRSs explained up to 1.6% of BP variance and 5.2% of HR variance among children of European ancestry. Genetic correlations between childhood and adulthood BP traits were moderate (rg = 0.4-0.7), suggesting age-specific genetic effects on BP. In the UK Biobank, higher childhood BP PRS levels were significantly associated with a broad range of adult health outcomes, particularly cardiometabolic outcomes such as hypertension, angina, myocardial infarction, and cardiovascular disease-related mortality.Conclusions These findings advance the understanding of the genetic architecture of childhood BP and HR and provide compelling genetic evidence linking childhood BP to a broad spectrum of adult health outcomes-particularly cardiometabolic conditions-which may inform targeted prevention strategies from a young age.

Introduction Metabolomics is the study of measured metabolites and low-molecular weight molecules in a biological specimen, collectively known as the metabolome. Measuring the metabolome in populations is useful for investigating complex, polygenic and multifactorial traits as it can give insight into cellular metabolism and its perturbations in various states of health and disease. Here we present a description of metabolomics data generated using an untargeted mass-spectrometry approach in two studies: (1) the Avon Longitudinal Study of Parents and Children (ALSPAC) - a healthy, general population; and (2) the By-Band-Sleeve trial (BBS) - a pragmatic randomised controlled trial (RCT) of metabolic and bariatric surgery (MBS) plus a non-randomised observational sub-study. Methods Samples for this work were collected from ALSPAC participants at 30 years of age. Two sample collection efforts were made within BBS – firstly, from the RCT comparing the effectiveness of three types of MBS: the Roux-en-Y gastric bypass (“bypass”), laparoscopic adjustable gastric band (“band”) and the sleeve gastrectomy (“sleeve”), and secondly from the non-randomised (observational) study of MBS. In both instances, samples were collected from patients before and after surgery. In total, 2128 samples were sent for mass-spectrometry (MS) metabolomics analysis by Metabolon (Discovery HD4 platform). Data underwent quality control (QC) via a standard pipeline using the R package metaboprep. Results After QC, the combined dataset consists of semi-quantitative data for 1176 features in 517 ALSPAC participants and 1062 BBS participants (1018 from the RCT and 44 from the non-randomised study) (1013 pre-surgery samples and 421 post-surgery samples). Conclusion Overall, we have provided a summary of MS data produced across two different study populations, described the QC procedures undertaken and provided some data validation analyses. Bringing together samples from these two studies in a single experiment offers a novel study design able to explore the biological implications of weight and intentional weight loss.

BACKGROUND:Multimorbidity, also known as multiple long-term conditions, is a major public health concern. Internalising and CardioMetabolic MultiMorbidity (ICM-MM) is a common form of mental-physical health multimorbidity, yet its genetic predisposition is largely unknown. We examined the polygenic nature of ICM-MM by assessing single trait-specific polygenic risk scores (PRSTRAIT) and whether combining them could increase the proportion of variance in liability to ICM-MM explained by genetic variation. METHODS:We developed PRSTRAIT using PRS-CS and summary statistics from the largest trait-specific GWAS excluding UK Biobank (UKB). We evaluated PRSTRAIT on ICM-MM risk in 206 452 UKB participants (n = 39 311 (19.0%) with ICM-MM) using logistic regression adjusted for gender and 10 genetic principal components, defining ICM-MM as lifetime occurrence of: ≥1 internalising (depression, anxiety, somatoform disorder) traits AND ≥ 1 cardiometabolic traits (type 2 diabetes, obesity, hypertension, dyslipidemia, chronic kidney disease). We used elastic net regression in a 50% training sample to generate ICM-MM-PRSTRAIT: a weighted combination of PRSTRAIT targeting ICM-MM. RESULTS:The strongest associations were between ICM-MM and PRSTRAIT for depression and type 2 diabetes-both odds ratios (OR) 1.18, [95% confidence interval (CI) 1.17-1.20] per standard deviation increase in PRSTRAIT. ICM-MM-PRSTRAIT retained five PRSTRAIT, with stronger associations (OR = 1.31, [95%CI 1.29-1.34]) than any PRSTRAIT in the testing sample. DISCUSSION:Combining several PRS explains more variance in ICM-MM liability than single-trait PRSs alone. ICM-MM-PRSTRAIT is a measure of genetic risk that could be used to examine premorbid stages of ICM-MM in external and youth cohorts, supporting awareness of earlier presentation and potentially avoidance or intervention.

Metabolomics is the study of measured metabolites and low-molecular weight molecules in a biological specimen, collectively known as the metabolome. Measuring the metabolome in populations is useful for investigating complex, polygenic and multifactorial traits as it can give insight into cellular metabolism and its perturbations in various states of health and disease. The Avon Longitudinal Study of Parents and Children (ALSPAC) is a birth cohort that enrolled pregnant women in 1991/92 and has followed them up ever since. Samples for this work were collected from ALSPAC participants at 30 years of age. By-Band-Sleeve (BBS) is a pragmatic randomised controlled trial (RCT) which evaluated the clinical effectiveness of three different types of bariatric surgery. Two sample collection efforts were made within BBS – firstly, from the RCT comparing the effectiveness of three types of bariatric surgery: the Roux-en-Y gastric bypass (“bypass”), laparoscopic adjustable gastric band (“band”) and the sleeve gastrectomy (“sleeve”), and secondly from a non-randomised (observational) study of bariatric surgery. In both instances, samples were collected from patients before and after surgery. Samples were sent for mass-spectrometry (MS) metabolomics analysis by Metabolon (Discovery HD4 platform). Bringing together samples from these two studies in a single experiment offers a novel study design able to explore the biological implications of – in this case – weight and intentional weight loss. Data underwent quality control (QC) via a standard pipeline using the R package metaboprep . Post-filtering, the dataset consists of semi-quantitative data for 1253 features in 517 ALSPAC participants and 1062 BBS participants (1018 from the RCT and 44 from the non-randomised study) (1013 pre-surgery samples and 421 post-surgery samples). Overall, we have provided a summary of MS data produced across two different study populations, described the QC procedures undertaken and provided some data validation analyses.

Aims/hypothesisDysglycaemia in youth results from complex interactions between genetic and environmental factors, yet their individual and combined contributions remain unclear. We aimed to: (1) evaluate the predictive performance of polygenic risk scores (PRSs) for glycaemic traits from childhood to early adulthood; (2) identify gene-environment interactions shaping glucose homeostasis trajectories; and (3) explore underlying mechanisms using pathway-specific PRSs.MethodsData from 8783 participants (aged 7-24 years) from the Avon Longitudinal Study of Parents and Children (ALSPAC) were used to compute 12 PRSs for type 2 diabetes, fasting glucose, insulin and BMI. Glycaemic outcomes, including insulin resistance, prediabetes (impaired fasting glucose) and type 2 diabetes, were assessed using fasting glucose and insulin (ages 7, 15, 18 and 24 years) and HbA1c (age 9 years). We evaluated whether PRSs could distinguish between transient (resolved by adulthood) and persistent glycaemic abnormalities using multinomial regression. We performed univariate and multivariate regressions, incorporating environmental factors (lifestyle, diet and maternal characteristics), and evaluated model performance using R2 and AUC. We tested interactions between PRS quintiles and environmental factors and explored pathophysiological mechanisms using pathway-specific PRSs.ResultsPrediabetes prevalence was up to 24% at age 24 years. PRS-enhanced models outperformed those using environmental factors alone (e.g. AUC for dysglycaemia at age 15 improved by 0.12, reaching 0.78). Fasting glucose PRS showed moderate ability to differentiate transient from persistent prediabetes (AUC=0.70). Gene-environment analyses revealed that high genetic risk combined with increased screen time or younger maternal age increased insulin resistance risk. Physical activity and health awareness attenuated this risk. Pathway analyses indicated insulin secretion as a key mechanism earlier in life, with insulin resistance emerging later.Conclusions/interpretationGenes interact with environment to define glucose homeostasis in youth, highlighting modifiable factors as actionable targets for early prevention.

Background The study of non-hospitalised COVID-19 cases provides a context for improved understanding of the immune response to existing and new infections. Population-based cohorts provide a unique opportunity to do this in relation to rich longitudinal pre- and pan-pandemic data. The Avon Longitudinal Study of Parents and Children (ALSPAC) is a prospective population-based cohort study which recruited pregnant women in 1990–1992 and has subsequently followed participants for over 30 years. Methods A study comprising three clinic visits was implemented, in response to the COVID-19 pandemic, amongst ALSPAC participants to measure SARS-CoV-2 specific humoral and cellular responses longitudinally. Here we present data from the first clinic in December 2020 before the start of the UK vaccination campaign and examine associations with a set of exemplar pre- and pan-pandemic health factors. Results We observed humoral and cellular memory immune responses to SARS-CoV-2 infection in mild cases of COVID-19 up to 9 months post-infection. Symptomatic infection elicited a memory immune response of greater magnitude, though there was variation in response in both asymptomatic and symptomatic individuals. We examined health factors associated with severe COVID-19 and found that cardio-metabolomic, respiratory and immune-related health factors associate with a memory immune response of higher magnitude. For example, in older participants (mean age 58 years), higher BMI was associated with an immune memory response of greater magnitude, particularly with anti-S and anti-N binding antibodies. Conclusions We set out to illustrate the use of cohort studies to deliver detailed immunological data and to provide example analyses of how life course health factors can be examined in relation to the immune response following a widespread and novel infection. We expanded this assessment to include longitudinally assessed traits, opening up the potential for the more common use of longitudinal population studies for the better understanding the aetiology of infection outcome.

Background: Clinical risk assessment for obesity-related disease relies largely on cross-sectional body mass index (BMI), overlooking how changes in BMI over time may inform metabolic risk. Methods: In 123,836 UK Biobank participants, we reconstructed 5-year retrospective BMI trajectories and examined associations between prior BMI slope (rate of BMI change) and multiple cardiometabolic and body composition biomarkers using a flexible modeling strategy. Findings: We show that BMI trajectory is a distinct axis of risk from current BMI: at the exact same BMI, individuals who have been gaining BMI have a more adverse metabolic profile than individuals with stable or declining BMI, particularly in liver enzymes, triglycerides, and blood pressure. Additionally, prior BMI change modified the relationship between current BMI and liver injury markers. These effects were strongest in men, at older ages, and at higher BMI. Imaging data from multiple cohorts at different ages indicated sex-specific fat partitioning, with recent weight gain preferentially associated with liver fat accumulation in men. In analyses of incident outcomes, BMI slope provided limited predictive information overall but showed an independent and complex association with stroke risk in men. Interpretation: These findings highlight the metabolic relevance and complexity of recent weight change beyond current BMI.

Background:Multi-system impacts of long COVID remain unknown. We aimed to compare multi-system deficits between people with long COVID and controls. Methods:We conducted a case-control study and recruited participants from two UK population-based cohorts: the Avon Longitudinal Study of Parents and Children (ALSPAC) and TwinsUK. Participants provided samples for SARS-CoV-2 serology between 2020 and 2021 and were asked about duration of COVID-19 symptoms between July and December 2021. Cases had long COVID (evidence of COVID-19 infection and persistent symptoms ≥4 weeks post infection); controls comprised 3 groups: acute COVID-19 only (symptoms reported for <4 weeks) and serological evidence of infection; self-reported long COVID-like symptoms but without wild-type SARS-CoV-2 virus antibodies; no symptoms or history of COVID-19 infection. People who were severely unwell or pregnant were excluded. Participants attended a clinic follow-up visit between 2021 and 2023 and underwent multi-system MRI, (cardiac, brain, lung, kidney), measurement of blood pressure and autonomic function, spirometry, renal function, exercise tests, strength and physical capability. Severity of deficit was then scored for each system as 0 (none) to 3 (severe). Primary outcome was a single composite multi-domain score summing each of nine domains: autonomic, brain, exercise capacity, heart, lungs, physical, renal, strength and vascular, with a maximum score of 27. Findings:In total, 349 participants, 141 with long COVID (40%) and 208 (60%) controls were recruited. Overall deficit score in cases was 0.22 (95% CI -0.44, 0.88) units greater than controls, adjusted for age, sex, ethnicity, cohort membership and relatedness. This estimate was little changed (0.32 (-0.34, 0.98)) when additionally adjusted for educational status, index of multiple deprivation, physical activity, smoking and co-morbidity. Restricting cases to those reporting symptoms including fatigue (n = 46) increased the excess deficit score to 0.81 (-0.19, 1.81) units in the minimally adjusted model. A difference was only observed in the vascular domain, largely attributable to elevated blood pressure, showing a 1.76 (1.04, 2.97) multivariable adjusted odds ratio excess in cases, and 3.04 (1.36, 6.80) when restricted to cases with fatigue. Interpretation:There was no evidence of marked residual subclinical deficits in most systems in people with long-COVID, although there was evidence of persistent deficits in the vascular system, largely related to elevated blood pressure. Mechanisms unrelated to organ dysfunction may contribute to symptoms. Blood pressure measurement and control should be included in clinical follow-up. Funding:Jointly funded by the National Institute for Health and Care Research and UK Research and Innovation (CONVALESCENCE, COV-LT-0009, MC_PC_20051).

High throughput metabolomic assays offer a huge opportunity to quantify the cellular processes underlying disease and intervention pathways. However, the multi-dimensional inter-relatedness between these processes coupled with the complex noisy measurement environment create a need for generation of new methods that move beyond simple pairwise associations. Here we develop a computationally simple, multivariate, relational comparison method called CLARITY to compare metabolomic data before and after an intervention. This generates a relational anomaly score that combines with traditional methods to increase classification performance of the underlying cause of changes to the levels of and covariances between metabolites. We demonstrate utility in the By-Band-Sleeve (BBS) clinical trial of bariatric surgery using NMR metabolomics data. On supplementing linear regression analysis with CLARITY, previously identified changes form two clusters that imply involvement in different underlying biological pathways. An additional cluster of metabolites are identified as undergoing a relational change which would not have been detected using traditional methods. Gathering insights about metabolites and the biomarkers they capture in the causal pathway between intervention and effect, from observations at scale, will inform the future design of modelling and laboratory experiments to capture the underlying biological process.

Background The study of non-hospitalised COVID-19 cases provides a context for improved understanding of the immune response to existing and new infections. Population-based cohorts provide a unique opportunity to do this in relation to rich longitudinal pre- and pan-pandemic data. The Avon Longitudinal Study of Parents and Children (ALSPAC) is a prospective population-based cohort study which recruited pregnant women in 1990–1992 and has subsequently followed participants for over 30 years. Methods A study comprising three clinic visits was implemented, in response to the COVID-19 pandemic, amongst ALSPAC participants to measure SARS-CoV-2 specific humoral and cellular responses longitudinally. Here we present data from the first clinic in December 2020 before the start of the UK vaccination campaign and examine associations with a set of exemplar pre- and pan-pandemic health factors. Results We observed humoral and cellular memory immune responses to SARS-CoV-2 infection in mild cases of COVID-19 up to 9 months post-infection. Symptomatic infection elicited a memory immune response of greater magnitude, though there was variation in response in both asymptomatic and symptomatic individuals. We examined health factors associated with severe COVID-19 and found that cardio-metabolomic, respiratory and immune-related health factors associate with a memory immune response of higher magnitude. For example, in older participants (mean age 58 years), higher BMI was associated with an immune memory response of greater magnitude, particularly with anti-S and anti-N binding antibodies. Conclusions We set out to illustrate the use of cohort studies to deliver detailed immunological data and to provide example analyses of how life course health factors can be examined in relation to the immune response following a widespread and novel infection. We expanded this assessment to include longitudinally assessed traits, opening up the potential for the more common use of longitudinal population studies for the better understanding the aetiology of infection outcome.

Announced in this Comment and in collaboration with Nature Medicine is the convening of the Data-Driven Decision Support in Obesity Management Commission, to promote adequate scientific evidence to support obesity management across global populations.

The major anxiety disorders (ANX; including generalized anxiety disorder, panic disorder and phobias) are highly prevalent, often onset early and cause substantial global disability. Although distinct in their clinical presentations, they probably represent differential expressions of a dysregulated threat-response system. Here, we present a genome-wide association meta-analysis comprising 122,341 European ancestry ANX cases and 729,881 controls. We identified 58 independent genome-wide significant risk variants and 66 genes with robust biological support. In an independent sample of 1,175,012 self-report ANX cases and 1,956,379 controls, 51 out of the 58 associations replicated. As predicted by twin studies, we found substantial genetic correlation between ANX and depression, neuroticism and other internalizing phenotypes. Follow-up analyses demonstrated enrichment in all major brain regions and highlighted GABAergic signaling as one potential mechanism implicated in ANX genetic risk. These results advance our understanding of the genetic architecture of ANX and prioritize genes for functional follow-up studies.

Establishing causality in nutrition research is challenging. While randomised controlled trials (RCTs) provide robust evidence, long-term dietary intervention studies with disease endpoints are often impractical. Short-term RCTs can instead identify intermediate traits that may lie on the causal pathway between diet and disease. Mendelian randomisation (MR) is an epidemiological approach that uses genetic variants as proxies for modifiable exposures to estimate the effects of lifelong differences in exposure on disease risk. However, the utility of MR is limited for complex dietary patterns because genetic variants typically reflect biological mechanisms rather than specific diets. We propose a two-step framework integrating dietary RCTs with MR to infer potential lifetime effects of dietary interventions. First, RCT data identify molecular traits altered by an intervention. Second, MR evaluates whether these traits are associated with long-term disease risk. We demonstrate this framework using the Diabetes Remission Clinical Trial (DiRECT), which measured circulating proteins and diabetes remission. Using protein data alone, 216 of 4,601 proteins changed following the intervention (step 1), and 10 were associated with diabetes risk using MR (step 2). We then compared these MR estimates with observed protein-remission associations from DiRECT. The broad agreement between the two (r≈−0.645, R2=0.416) supports this framework as a useful approach for estimating long-term effects of dietary interventions.

Abstract Background Observational evidence suggests ultra-processed food (UPF) may contribute to obesity, but some people who consume a larger amount of UPF remain at normal weight. This study examined whether childhood UPF consumption was associated with obesity in early adulthood and whether the association was modified by genetic susceptibility to body mass index (BMI). Methods This prospective cohort study included data from 3061 participants of the Avon Longitudinal Study of Parents and Children (ALSPAC) in England with follow-up from 7 to 24 years. UPF consumption was calculated from food diaries based on the NOVA classification. LDpred2 was used to construct a polygenic score (PGS) for body mass index (BMI). Linear regression models were used to estimate the association between UPF intake at 7 years and BMI at 24 years. The PGS-UPF interaction was examined to see whether genetic susceptibility modifies the association between childhood UPF consumption and early adulthood BMI. Results Each 10% increase in the proportion of total energy intake coming from UPF at 7 was associated with 0.21 (95% CI 0.05–0.37) kg/m2 higher BMI at 24, after adjusting for BMI at 7, age, sex, ethnicity, physical activity, socioeconomic position, and total energy intake. There is evidence for PGS-BMI interaction (0.19; 95% CI 0.02–0.36), and the UPF-BMI association was only retained in children with the highest genetic predisposition to higher BMI (0.74, 95% CI 0.07–1.42) in the subgroup analysis. Conclusions UPF consumption in childhood is only associated with early adulthood obesity among children more genetically predisposed to higher BMI.

IL-6 responses are ubiquitous in Mycobacterium tuberculosis (Mtb) infections, but their role in determining human tuberculosis (TB) disease risk is unknown. We used single nucleotide polymorphisms (SNPs) in and near the IL-6 receptor (IL6R) gene, focusing on the non-synonymous variant, rs2228145, associated with reduced classical IL-6 signalling, to assess the effect of altered IL-6 activity on TB disease risk. We identified 16 genome wide association studies (GWAS) of TB disease collating 17,982 cases of TB disease and 972,389 controls across 4 continents. Meta-analyses and Mendelian randomisation analyses revealed that reduced classical IL-6 signalling was associated with lower odds of TB disease, a finding replicated using multiple, independent SNP instruments and 2 separate exposure variables. Our findings establish a causal relationship between IL-6 signalling and the outcome of Mtb infection, suggesting IL-6 antagonists do not increase the risk of TB disease and should be investigated as adjuncts in treatment.

Background:There are substantial age-related changes in emotional and behavioural problems over childhood. In order to establish the impact of the Covid-19 pandemic on child emotional and behavioural problems, longitudinal designs which take into account age-related trends are needed. This study examined trajectories of children's emotional and behavioural difficulties both before and during the pandemic in a prospective birth cohort. Methods:Data were from 708 children from the third generation of a birth cohort study; the Avon Longitudinal Study of Parents and Children in England. The study population comprised of 708 children (median age at COVID data collection was 2.75 years [interquartile range 0.8, 4.4]) whose parents provided pre-pandemic surveys and a survey between 26 May and 5 July 2020. Multi-level mixed effects models with random intercepts and slopes examined whether children's trajectories of emotional and behavioural difficulties during the pandemic differ from those expected pre-pandemic. Results:Children's emotional and behavioural difficulties trajectories pre-pandemic increased during infancy peaking around the age of 2 and then declined throughout the rest of childhood. Pre-pandemic, decline in difficulties scores after age 2 was 0.6 points per month; but reduced by 35% during the pandemic. This slower decline in scores translated to older children having difficulty scores higher than would be expected, during the pandemic. By age 8.5, there is a 9.5-point difference in pre- and during-pandemic scores (95% CI: 4.5-14.5). This represents an average 48% increase from scores expected at this age (pre-pandemic mean score = 20; 95% CI: [15-25]). Results remained similar although somewhat attenuated after adjusting for parental anxiety. Conclusion:The COVID-19 pandemic may be associated with greater persistence of emotional and behavioural difficulties after the age of 2 years.

Objective:This prospective, double-blind, adaptive recall-by-genotype study assessed the effects of nonsynonymous variation in transient receptor potential ankyrin 1 (TRPA1) on thermal and mechanical detection and pain thresholds before and after topical application of the TRPA1 agonist cinnamaldehyde.Methods:Five putative gain-of-function TRPA1 variants were assessed within the ALSPAC cohort (aged 27-30). After accounting for linkage disequilibrium, 3 TRPA1-allele groups were considered for recruitment with the reference alleles considered as a control. An interim cohort was recruited, per protocol, from homozygous carriers of a group (rs7819749) with an equal number of controls (N = 15/group).Results:Interim analysis demonstrated a lower heat pain threshold of 2.4 degrees C (d = 0.6) suggestive of a TRPA1 gain-of-function, with a predicted 80% statistical power at full enrolment, thus recruitment continued for rs7819749. At full enrolment (N = 99), there was no observed effect of rs7819749 on heat pain threshold or any other nociceptive modality in na & iuml;ve or cinnamaldehyde-sensitised skin. The lack of heat hyperalgesia was replicated in a population sample having quantitative sensory test data, the TwinsUK cohort. As expected, topical cinnamaldehyde induced a robust flare and a reduction in heat pain threshold (P < 0.05), but in contrast to previous reports, it did not alter cold pain threshold, nor did it produce mechanical hyperalgesia.Conclusion:The novel adaptive study design successfully balanced a 20% risk of incorrect interim assessment while optimising the power to observe sensory changes using small cohorts. Post-hoc simulation confirmed that the correct decision to terminate the study of a particular variant was performed in over 94% of permutations at our chosen interim point (N = 15).